Posts Tagged ‘results’
Has anyone used alternative medicine for type 2 diabetes with good results?
I’m sick of taking so many pills for diabetes and heart disease. I would like to hear from someone that has used all natural remedies with excellant results.
{answer}
(AFX UK Focus) 2010-06-26 16:55 Roche says diabetes drug studies show good results
(AFX UK Focus) 2010-06-26 16:55 Roche says diabetes drug studies show good results
ZURICH, June 26 (Reuters) – Swiss drugmaker Roche’s experimental diabetes drug taspoglutide showed good results in a series of late-stage studies, the group said on Saturday, after the drug suffered a severe setback just recently. Roche launched a risk mitigation programme for the drug developed under license from French group Ipsen after hypersensitivity problems were seen in some patients …
Has anyone had positive results with alternative adult onset (type 2) diabetes treatments?
I am interested in finding out any and all alternative (besides the regular medical advice) type 2 diabetes treatments.Any answers are welcome-thanks.
Study Shows AFREZZA™ Controls Blood Sugar Levels In Type 1 Diabetes, Results In Weight Loss, Less Hypoglycemia Than …
Study Shows AFREZZA™ Controls Blood Sugar Levels In Type 1 Diabetes, Results In Weight Loss, Less Hypoglycemia Than …
Diabetes treatment regimens containing AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence of hypoglycemia in patients with Type 1 diabetes and poorly controlled blood sugar levels, according to a two-year study presented today at the …
Santarus to Hold First Quarter 2010 Financial Results Conference Call on May 6
Santarus to Hold First Quarter 2010 Financial Results Conference Call on May 6
SAN DIEGO—-Santarus, Inc. , a specialty biopharmaceutical company, today announced that it will release first quarter 2010 financial results after market close on Thursday, May 6, 2010.
Positive top-line results from Phenomix’ Phase 3 trial of dutogliptin for Type 2 diabetes mellitus
Positive top-line results from Phenomix’ Phase 3 trial of dutogliptin for Type 2 diabetes mellitus
Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix’ internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.
Biodel’s VIAject insulin Phase 3 study results to be presented at international diabetes conference in Basel
Biodel’s VIAject insulin Phase 3 study results to be presented at international diabetes conference in Basel
Biodel, Inc. announced today that its chief executive officer, Dr. Sol Steiner, will present results from the company’s two Phase 3 studies with VIAject® ultra-rapid-acting recombinant human insulin in a platform presentation at the 3rd International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland, on Friday, February 12, 2010, at 1pm central European time.